Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

ZOLEDRONIC ACID

ZOLEDRONIC ACID

Standard Dose
EQ 4MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ZOLEDRONIC ACID is listed in Drugs@FDA under application 090018 (ANDA).

Marketing status: Discontinued Active ingredient ZOLEDRONIC ACID Form and strength INJECTABLE;INTRAVENOUS - EQ 4MG BASE/VIAL Sponsor SUN PHARMA GLOBAL Submission history Latest submission status date: 2013-03-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview ZOLEDRONIC ACID is listed in Drugs@FDA under application 090018 (ANDA). Marketing status: Discontinued Active ingredient ZOLEDRONIC ACID Form and strength INJECTABLE;INTRAVENOUS - EQ 4MG BASE/VIAL Sponsor SUN PHARMA GLOBAL Submission history Latest submission status date: 2013-03-04 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.